Yasuyuki Kakihana - Journalist Profile | Connect with top journalists

Beats

Biography

Content

Total articles 3

• Available on paid plans

  Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial

  By Yasuyuki Kakihana, Osamu Nishida, Takumi Taniguchi, Masaki Okajima

  Mar. 31, 2020

• Available on paid plans

  Is early goal-directed therapy associated with a higher risk of adverse events?

  By Ahmad Sabry Saleh, Yasuyuki Kakihana

  Nov. 27, 2018

• Available on paid plans

  Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial

  By Yasuyuki Kakihana, Osamu Nishida, Takumi Taniguchi, Masaki Okajima

  Mar. 31, 2020

As seen in

Company Info